Pathogen-reduced platelets are one of the newest blood components manufactured by Canadian Blood Services. Pathogen-reduced platelets, also known as pooled platelets psoralen-treated or “PPPT”, were first introduced to hospitals served by our Ottawa production site in January 2022. In March 2023, their roll-out continued to include hospitals served by our Dartmouth production site. Why manufacture pathogen-reduced platelets? By implementing pathogen-reduced platelets, Canadian Blood Services joins many other countries around the world who are using pathogen inactivation technology. The

Our partnership with the Centre for Blood Research (CBR) at the University of British Columbia is helping to train the next generation of researchers in transfusion science. This blog post highlights just some of the achievements in education, training or knowledge mobilization accomplished by CBR trainees. Dr. Peter Bell, a research associate in Dr. Christopher Overall’s laboratory at the Centre for Blood Research, received second prize in Canadian Blood Services’ Research 180 Video Competition earlier in 2023 for an original video showcasing his research. In the blog below, Peter reflects on